Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients

NCT03710655 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
468
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Apimeds, Inc.